Eporise 4000 Injection: Comprehensive Medicine Guide
When to Call Your Doctor IMMEDIATELY
- Chest pain, shortness of breath, or difficulty breathing
- Sudden weakness or numbness on one side of the body
- Severe headache with blurred vision or confusion
- Swelling, pain, or redness in one leg
- Seizures or loss of consciousness
- Signs of severe allergic reaction such as swelling of face, lips, or throat
- Uncontrolled high blood pressure
If experiencing severe symptoms, call emergency services immediately.
What is erypro 4000iu injection used for?
This medicine is a recombinant human erythropoietin alfa injection used to treat anemia in chronic kidney disease, chemotherapy-induced anemia, and other conditions. It stimulates red blood cell production and is given by a healthcare professional.
- Generic Name: Recombinant Human Erythropoietin Alfa (4000IU)
- Manufacturer: Biocon
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 erypro 4000iu injection के बारे में (Hindi Summary)
उपयोग: यह दवा रीनल एनीमिया, कीमोथेरेपी से होने वाले एनीमिया, और एचआईवी रोगियों में जिडोवुडीन से होने वाले एनीमिया के इलाज के लिए इस्तेमाल की जाती है। यह शरीर में लाल रक्त कोशिकाओं का उत्पादन बढ़ाकर एनीमिया को ठीक करती है। यह इंजेक्शन के रूप में डॉक्टर या नर्स द्वारा दी जाती है।
साइड इफेक्ट्स: आम दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, जोड़ों में दर्द, मतली और इंजेक्शन स्थल पर प्रतिक्रिया शामिल हैं। गंभीर दुष्प्रभावों में रक्त के थक्के बनना, दौरे पड़ना, और शुद्ध लाल कोशिका अप्लासिया शामिल हो सकते हैं।
सुरक्षा सलाह: यह दवा केवल डॉक्टर की देखरेख में ही दी जानी चाहिए। रक्तचाप और हीमोग्लोबिन की नियमित जांच करवाएं। यदि सीने में दर्द, सांस लेने में कठिनाई, या पैरों में सूजन हो तो तुरंत डॉक्टर से संपर्क करें। बिना डॉक्टर की सलाह के इस दवा का सेवन न करें।
💊 erypro 4000iu injection Uses & Benefits
[{"condition":"Anemia of chronic kidney disease","description":"This medicine is used to treat anemia in patients with chronic kidney disease who are not on dialysis or are on dialysis, to maintain hemoglobin levels and reduce the need for blood transfusions.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anemia","description":"This medicine is used to treat anemia in cancer patients receiving myelosuppressive chemotherapy, to reduce transfusion requirements and improve quality of life.","evidence":"Well-established"},{"condition":"Anemia in HIV-infected patients on zidovudine","description":"This medicine is used to treat anemia associated with zidovudine therapy in HIV-positive patients, with endogenous erythropoietin levels ≤500 mU/mL.","evidence":"Well-established"},{"condition":"Anemia in patients undergoing surgery","description":"This medicine may be used to reduce the need for allogeneic blood transfusions in patients undergoing elective, non-cardiac, non-vascular surgery with a high risk of transfusion.","evidence":"Established"}]
Off-label uses: [{"condition":"Anemia in myelodysplastic syndromes","description":"Sometimes prescribed off-label to treat anemia in patients with low-risk myelodysplastic syndromes, though response rates vary.","evidence":"Limited"},{"condition":"Anemia of prematurity","description":"Occasionally used off-label in premature infants to reduce transfusion needs, but evidence is conflicting.","evidence":"Limited"}]
Primary treatment for: Anemia associated with chronic kidney disease
Also treats: Chemotherapy-induced anemia, Anemia in HIV-infected patients on zidovudine, Anemia in patients undergoing surgery
📋 Drug Information
| Generic Name(s) | Recombinant Human Erythropoietin Alfa (4000IU) |
| Brand Name | erypro 4000iu injection |
| Manufacturer | Biocon |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | BLOOD RELATED |
| Action Class | Erythropoiesis-stimulating agent (ESA) |
| Route of Administration | Parenteral (intravenous or subcutaneous) |
| Storage | Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not shake. Protect from light. Keep in original carton until use. |
| Shelf Life | 24 months from the date of manufacture. |
| WHO Guideline | The World Health Organization (WHO) includes recombinant human erythropoietin in its Model List of Essential Medicines for the treatment of anemia in chronic kidney disease and cancer. However, specific recommendations should be based on current clinical guidelines. |
| ICMR Guideline | Not established from the available information. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
Recombinant human erythropoietin alfa is a glycoprotein that binds to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates intracellular signaling pathways, including JAK2/STAT5, which promote cell survival, proliferation, and differentiation into mature red blood cells. By stimulating erythropoiesis, it increases red blood cell production and hemoglobin levels, thereby correcting anemia.
Mechanism Steps
💡 How to Take erypro 4000iu injection
Strength: Injection: 4000 IU per vial or prefilled syringe.
Dosage Information
| Adult Dosage | The dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For chronic kidney disease, the typical starting dose is 50-100 IU/kg three times per week intravenously or subcutaneously. For chemotherapy-induced anemia, the starting dose is 150 IU/kg three times per week subcutaneously or 40,000 IU weekly. For zidovudine-treated HIV patients, the dose is 100 IU/kg three times per week. Dose adjustments are made based on hemoglobin levels, with a target not exceeding 12 g/dL. Always follow your healthcare provider's instructions. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | Elderly patients may be more sensitive to the effects of this medicine, particularly regarding blood pressure and cardiovascular risks. Dosing should be individualized by a clinician, and monitoring should be more frequent. |
| Renal Impairment | In patients with chronic kidney disease, the dose should be individualized based on hemoglobin levels and clinical response. More frequent monitoring is required. The target hemoglobin should not exceed 12 g/dL. |
| Hepatic Impairment | No specific dosage adjustments are established for hepatic impairment. Use with caution and monitor closely. |
| Maximum Daily Dose | Not established from the available information. Dosing is individualized. |
Dosage Timeline
🍽️ Food Timing Guide
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of erypro 4000iu injection
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🔬 Drug Interactions
| Drug | Severity | Effect |
|---|---|---|
| Antihypertensives | Major | |
| Anticoagulants | Major | |
| Iron supplements | Moderate | |
| ACE inhibitors | Moderate | |
| Cyclosporine | Minor |
🚨 Major Interactions
- Antihypertensive agents
- Anticoagulants (e.g., warfarin, heparin)
⚡ Moderate Interactions
- Iron supplements
- Angiotensin-converting enzyme inhibitors (ACEIs)
🍷 Alcohol Interaction
Alcohol may increase the risk of hypertension and may worsen anemia. It is advisable to avoid or limit alcohol consumption while on this medicine.
🔎 Check Your Other Medicines
Educational tool. Always confirm with your doctor or pharmacist.
🛡️ Safety & Warnings
🚫 Contraindications
["Uncontrolled hypertension","Hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with anemia due to iron deficiency, folate deficiency, or other correctable causes without addressing the deficiency"]
⚠️ Warnings & Precautions
["Increased risk of thromboembolic events, including stroke, myocardial infarction, and venous thromboembolism.","Hypertension may occur or worsen; monitor blood pressure closely.","Seizures have been reported, especially in patients with chronic kidney disease.","Pure red cell aplasia may occur; evaluate if sudden loss of efficacy.","May increase the risk of tumor progression or recurrence in cancer patients.","Use with caution in patients with cardiovascular disease.","Ensure adequate iron, folate, and vitamin B12 before and during therapy."]
🤱 Lactation Safety
It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman.
💊 Overdose Management
Overdose may lead to excessive erythropoiesis, resulting in polycythemia and increased risk of thromboembolic events. Treatment is symptomatic and supportive. In case of overdose, discontinue the medicine and monitor hemoglobin and hematocrit. Phlebotomy may be considered if necessary.
⏰ Missed Dose
If a dose is missed, contact your healthcare provider for guidance. Do not double the dose to catch up. The dosing schedule should be individualized by your clinician.
Additional Safety Advice
This medicine should only be administered by a healthcare professional. Blood pressure must be monitored closely before and during therapy. Hemoglobin levels should be checked regularly to avoid excessive increases. Patients should report any signs of blood clots, such as chest pain, shortness of breath, or swelling in the legs. Do not use this medicine if you have uncontrolled hypertension or a history of pure red cell aplasia. Inform your doctor about all other medications, especially those that affect blood pressure or blood clotting. Avoid self-administration unless trained and instructed by a healthcare provider.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients may be more susceptible to cardiovascular events and hypertension. Dosing should be individualized, and monitoring should be more frequent. The target hemoglobin should be the lowest level sufficient to avoid transfusions.
🤰 Pregnancy Planning (TTC)
If you are planning to become pregnant, discuss with your doctor. This medicine is Pregnancy Category C and should be used during pregnancy only if clearly needed. Effective contraception may be advised while on therapy.
🏥 Post-Surgery Considerations
This medicine may be used to reduce the need for blood transfusions in patients undergoing certain surgeries. It should be administered under medical supervision. Monitor for thromboembolic events postoperatively.
🦷 Dental Procedures
Inform your dentist that you are receiving this medicine. There are no specific contraindications for dental procedures, but if you have a bleeding disorder or are on anticoagulants, additional precautions may be needed.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
Moderate exercise is generally safe, but avoid strenuous activities if you have severe anemia or cardiovascular disease. Consult your doctor before starting any exercise program. If you experience chest pain, shortness of breath, or dizziness during exercise, stop and seek medical attention.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
This medicine may cause dizziness or seizures in some patients. Avoid driving or operating heavy machinery if you experience these effects. Most patients can continue their normal activities, but fatigue and other symptoms of anemia may affect work performance until hemoglobin levels improve. Discuss any work-related concerns with your doctor.
🛑 When to Stop This Medicine
Do not stop this medicine without consulting your doctor. Discontinuation may be considered if you experience serious side effects, if your hemoglobin levels are maintained without it, or if the risks outweigh the benefits. Your doctor will determine the appropriate time to stop therapy.
📅 Long-Term Use Effects
Long-term use of this medicine may increase the risk of cardiovascular events, including stroke, myocardial infarction, and heart failure, especially when targeting higher hemoglobin levels. Regular monitoring of hemoglobin, blood pressure, and iron stores is required. The dose should be adjusted to maintain the lowest hemoglobin level sufficient to avoid transfusions. Periodic evaluation of the risk-benefit ratio is necessary.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
If iron deficiency is the cause of anemia, iron supplements may be used alone or in combination with this medicine.
Evidence: Well-establishedMay be used for severe anemia or when this medicine is ineffective or contraindicated.
Evidence: Well-establishedLonger-acting erythropoiesis-stimulating agents that require less frequent dosing.
Evidence: Well-established💉 Vaccination Considerations
💉 If You're Getting Vaccinated
There are no specific vaccine interactions reported with this medicine. However, patients with chronic kidney disease or cancer may have altered immune responses. Consult your doctor regarding vaccination schedules.
📦 Storage Guide
✅ DO
Store refrigerated at 2°C to 8°C (36°F to 46°F)
❌ DON'T
Do not freeze
✅ DO
Keep in original carton to protect from light
❌ DON'T
Do not shake the vial
✅ DO
Inspect solution before use
❌ DON'T
Do not use if particles or discoloration are present
✈️ Traveling with This Medicine
When traveling with this medicine, carry it in its original packaging with the prescription label. Keep it refrigerated using a cool pack or insulated bag. Carry a copy of your prescription and a letter from your doctor explaining the medical need. Check airline regulations for carrying injectables and refrigerated medications. If crossing time zones, consult your doctor about adjusting the dosing schedule. Do not expose the medicine to extreme temperatures.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: An increase in reticulocyte count can be seen within 7 to 10 days. A significant rise in hemoglobin may take 2 to 6 weeks.
A: This medicine should be administered by a healthcare professional. Self-administration is only allowed if you have been trained and instructed by your doctor.
A: Contact your healthcare provider for guidance. Do not double the dose to catch up.
A: It is Pregnancy Category C. Use only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.
A: Serious side effects include thromboembolic events, hypertensive crisis, seizures, and pure red cell aplasia. Seek immediate medical attention if you experience symptoms.
🤔 Common Patient Concerns
🔄 Substitutes for erypro 4000iu injection
View AllAlternative brands with exact same active ingredient:
-
esa 4000 injectionSeptalyst Lifesciences Pvt.Ltd. ₹928.13 9.1% CHEAPER
-
epofer 4000iu injectionEmcure Pharmaceuticals Ltd ₹950.00 7% CHEAPER
-
relipoietin 4000iu injectionReliance Life Sciences ₹1,056.00 3.4% COSTLIER
-
erypro safe 4000iu injectionBiocon ₹1,061.90 4% COSTLIER
-
repoitin 4000 injectionSerum Institute Of India Ltd ₹1,123.02 10% COSTLIER
Medical Note: Always consult your doctor before switching medications.
🛑 Myths vs. Facts
- Myth: This medicine can be used to treat all types of anemia.
Fact: This medicine is only effective for anemia caused by inadequate erythropoietin production, such as in chronic kidney disease. It is not effective for iron deficiency anemia or other correctable causes. - Myth: This medicine can be self-administered without training.
Fact: This medicine should only be administered by a healthcare professional or a trained individual under medical supervision. - Myth: Higher doses of this medicine always work better.
Fact: Higher doses may increase the risk of serious cardiovascular events. The dose should be individualized to maintain hemoglobin within the target range.
🔄 Alternative Options
Generic Alternatives
- Recombinant human erythropoietin alfa
Brand Alternatives
- Eporise 4000 injection